Sampling or node dissection for intraoperative staging of lung cancer: a multicentric cross-sectional study

被引:45
作者
Massard, Gilbert [1 ]
Ducrocq, Xavier
Kochetkova, Evgenia A.
Porhanov, Vladimir A.
Riquet, Marc
机构
[1] Hop Civil, Serv Chirurg Thorac, F-67091 Strasbourg, France
[2] Ctr Cardiothorac, Krasnodar 350086, Russia
[3] Hop Europeen Georges Pompidou, Serv Chirurg Thorac, F-75908 Paris, France
关键词
surgery; lung cancer; lymph node dissection;
D O I
10.1016/j.ejcts.2006.04.010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This study compares accuracy of sampling versus format node dissection in patients with primary lung cancer. Patients and methods: During a 4-month period, 208 consecutive patients (172 men, 36 women) without bulky disease underwent resection for primary lung cancer in three centers. The surgeon first sampled the main lymph node stations, and subsequently performed a radical mediastinal dissection. Endpoints were accuracy of prediction for stage N2 and radicality of node sampling compared to dissection. Results: Resection consisted of 1 segmentectomy, 142 standard lobectomies, 6 bitobectomies, 14 sleeve-lobectomies, and 45 pneumonectomies. There were 108 squamous cell carcinomas, 621 adenocarcinomas, 18 bronchoalveolar carcinomas, 8 large cell carcinomas, 4 adenosquamous carcinomas and 8 neuroendocrine carcinomas. Primary tumor was stage T1 in 49 patients, T2 in 110, T3 in 43, and T4 in 6. Lymph node status (dissection) was NO in 113, N1 in 35, and N2 in 60 patients. N2 disease concerned a single node in 16, a single node station in 19, and multiple levels in 25. Both N1 and N2 nodes were diseased in 36 patients. Sampling adequately recognized N2 disease in 31 patients (52%). Multiple level N2 was accurately identified in 10 patients (40%). Resection based on sampling would have been incomplete in 53 patients (88%). Conclusion: Radical mediastinal dissection is a mandatory adjunct to resection for lung cancer with curative attempt. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:164 / 167
页数:4
相关论文
共 11 条
[1]   The role of FDG-PET scan in staging patients with nonsmall cell carcinoma [J].
Cerfolio, RJ ;
Ojha, B ;
Bryant, AS ;
Bass, CS ;
Bartalucci, AA ;
Mountz, JM .
ANNALS OF THORACIC SURGERY, 2003, 76 (03) :861-866
[2]   Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer [J].
Depierre, A ;
Milleron, B ;
Moro-Sibilot, D ;
Chevret, S ;
Quoix, E ;
Lebeau, B ;
Braun, D ;
Breton, JL ;
Lemarié, E ;
Gouva, S ;
Paillot, N ;
Bréchot, JM ;
Janicot, H ;
Lebas, FX ;
Terrioux, P ;
Clavier, J ;
Foucher, P ;
Monchâtre, M ;
Coëtmeur, D ;
Level, MC ;
Leclerc, P ;
Blanchon, F ;
Rodier, JM ;
Thiberville, L ;
Villeneuve, A ;
Westeel, V ;
Chastang, C .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (01) :247-253
[3]   Does the extent of lymph node dissection influence outcome in patients with stage I non-small-cell lung cancer? [J].
Doddoli, C ;
Aragon, A ;
Barlesi, F ;
Chetaille, B ;
Robitail, S ;
Giudicelli, R ;
Fuentes, P ;
Thomas, P .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 27 (04) :680-685
[4]   Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer [J].
Gajra, A ;
Newman, N ;
Gamble, GP ;
Kohman, LJ ;
Graziano, SL .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (06) :1029-1034
[5]   Comparison of imaging TNM [(i)TNM] and pathological TNM [pTNM] in staging of bronchogenic carcinoma [J].
Gdeedo, A ;
VanSchil, P ;
Corthouts, B ;
VanMieghem, F ;
VanMeerbeeck, J ;
VanMarck, E .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 12 (02) :224-227
[6]   Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer [J].
Keller, SM ;
Adak, S ;
Wagner, H ;
Johnson, DH .
ANNALS OF THORACIC SURGERY, 2000, 70 (02) :358-365
[7]   Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer [J].
Lardinois, D ;
Suter, H ;
Hakki, H ;
Rousson, V ;
Betticher, D ;
Ris, HB .
ANNALS OF THORACIC SURGERY, 2005, 80 (01) :268-275
[8]   Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer [J].
Le Chevalier, T ;
Arriagada, R ;
Le Péchoux, C ;
Grunenwald, D ;
Dunant, A ;
Pignon, JP ;
Tarayre, M ;
Abratt, R ;
Arriagada, R ;
Bergman, B ;
Gralla, R ;
Grunenwald, D ;
Le Chevalier, T ;
Orlowski, T ;
Papadakis, E ;
Pinel, MIS ;
Araujo, C ;
Della Torre, H ;
de Solchaga, MM ;
Abdi, E ;
Blum, R ;
Ball, D ;
Basser, R ;
De Boer, R ;
Bishop, J ;
Brigham, B ;
Davis, S ;
Fox, D ;
Richardson, G ;
Wyld, D ;
Pirker, R ;
Humblet, Y ;
Delaunois, L ;
Van Meerbeeck, JP ;
Germonpre, P ;
Vansteenkiste, J ;
Nackaerts, K ;
Pinel, MIS ;
Vauthier, G ;
Younes, RN ;
Arriagada, R ;
Baeza, R ;
Carvajal, P ;
Kleinman, S ;
Orlandi, L ;
Castro, C ;
Godoy, J ;
Kosatova, K ;
Gaafar, R ;
Azarian, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (04) :351-360
[9]   The size of metastatic foci and lymph nodes yielding false-negative and false-positive lymph node staging with positron emission tomography in patients with lung cancer [J].
Nomori, H ;
Watanabe, K ;
Ohtsuka, T ;
Naruke, T ;
Suemasu, K ;
Uno, K .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2004, 127 (04) :1087-1092
[10]   Prognostic value of T and N in non small, cell lung cancer three centimeters or less in diameter [J].
Riquet, M ;
Manach, D ;
Barthes, FKP ;
Dujon, A ;
Debrosse, D ;
Debesse, B .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1997, 11 (03) :440-444